{"id":61596,"date":"2024-03-03T06:01:14","date_gmt":"2024-03-03T06:01:14","guid":{"rendered":"https:\/\/medsname.com\/bicalumutide\/"},"modified":"2026-04-30T10:23:34","modified_gmt":"2026-04-30T10:23:34","slug":"bicalumutide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/bicalumutide\/","title":{"rendered":"Bicalumutide"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Bicalumutide?<\/h3>\n<p style=\"margin:0;\"><strong>Bicalumutide<\/strong> egy tabletta form\u00e1j\u00fa gy\u00f3gyszer a Cipla gy\u00e1rt\u00e1s\u00e1ban, mely <strong>bicalutamide 50 mg<\/strong> -t tartalmaz, egy nem szteroid <strong>androg\u00e9nreceptor-antagonista (antiandrog\u00e9n)<\/strong> alkalmazott <strong>fejlett vagy metastatikus prosztatar\u00e1k<\/strong>. Szabv\u00e1nyos alkalmaz\u00e1s: kombin\u00e1ci\u00f3ban egy <strong>LHRH agonist\u00e1val<\/strong> (goszerelin, leuprorelin) kombin\u00e1lt androg\u00e9n blok\u00e1d (CAB) c\u00e9lj\u00e1b\u00f3l. Szabv\u00e1nyos adag: <strong>50 mg once daily (with LHRH agonist) or 150 mg once daily (monotherapy)<\/strong>. Main side effects: gynaecomastia and breast tenderness (common), hot flushes, hepatotoxicity (mandatory LFT monitoring), reduced libido, rare interstitial pneumonitis. <strong>K\u00f6telez\u0151: kiindul\u00e1si + havi m\u00e1jfunkci\u00f3-vizsg\u00e1lat az els\u0151 4 h\u00f3napban, majd id\u0151szakos.<\/strong><\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Szakorvosi fel\u00fcgyelet sz\u00fcks\u00e9ges.<\/strong> A r\u00e1kk\u00e9sz\u00edtm\u00e9nyeket csak kezel\u0151 onkol\u00f3gus \u00edrhatja fel meger\u0151s\u00edtett diagn\u00f3zis, kiindul\u00e1si st\u00e1diummeghat\u00e1roz\u00e1s \u00e9s meghat\u00e1rozott kezel\u00e9si terv mellett. Soha ne kezdjen el, ne szak\u00edtson meg, ne m\u00f3dos\u00edtson adagot, \u00e9s ne haszn\u00e1ljon r\u00e1kk\u00e9sz\u00edtm\u00e9nyt onkol\u00f3giai ell\u00e1t\u00e1si terven k\u00edv\u00fcl. A legt\u00f6bb r\u00e1kk\u00e9sz\u00edtm\u00e9ny rendszeres v\u00e9rvizsg\u00e1lati monitoroz\u00e1st ig\u00e9nyel (teljes v\u00e9rk\u00e9p, m\u00e1jfunkci\u00f3, vesefunkci\u00f3), abszol\u00fat kontraindik\u00e1lt terhess\u00e9g alatt, \u00e9s jelent\u0151s gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sokkal rendelkezik.<\/div>\n<h2 class=\"wp-block-heading\">What Is Bicalumutide?<\/h2>\n<p>Bicalumutide is an oral tablet from Cipla containing <strong>bicalutamide 50 mg<\/strong>. Bicalutamide is a non-steroidal anti-androgen that competitively blocks the androgen receptor in prostate cancer cells, inhibiting the proliferative effect of testosterone and dihydrotestosterone (DHT). It is used in <strong>fejlett vagy metastatikus prosztatar\u00e1k<\/strong>, szinte mindig LHRH-agonist\u00e1val (goszrelin, leuprorelin, triptorelin) kombin\u00e1lva a <strong>kombin\u00e1lt androg\u00e9nblok\u00e1d (CAB) c\u00e9lj\u00e1b\u00f3l<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\">How Does Bicalumutide Work?<\/h2>\n<p>Prostate cancer growth is driven by androgen-receptor signalling. Standard androgen deprivation therapy (ADT) suppresses ovarian androgen production through LHRH agonists. However, the adrenal glands continue to produce ~10% of total body androgens, and the residual signal is enough to drive disease progression in many patients. Bicalumutide blocks the androgen receptor itself, so the residual adrenal androgens cannot signal &mdash; producing more complete androgen blockade.<\/p>\n<ul>\n<li><strong>Kompetit\u00edv androg\u00e9nreceptor-antagonista<\/strong> \u2014 k\u00f6t\u0151dik az AR-hez \u00e9s megakad\u00e1lyozza, hogy a tesztoszteron\/DHT aktiv\u00e1lja azt.<\/li>\n<li><strong>Long half-life (~6 days)<\/strong> &mdash; once-daily oral dosing.<\/li>\n<li><strong>A \u201ctumor fell\u00e1ngol\u00e1s\u201d megel\u0151z\u00e9s\u00e9re haszn\u00e1lj\u00e1k\u201d<\/strong> az LHRH-agonist\u00e1s kezel\u00e9s megkezd\u00e9sekor \u2013 a kezdeti LHRH \u00e1ltal induk\u00e1lt tesztoszteron-l\u00f6ket \u00e1tmenetileg s\u00falyosb\u00edthatja a betegs\u00e9get, az antiandrog\u00e9nnel t\u00f6rt\u00e9n\u0151 el\u0151kezel\u00e9s pedig ezt blokkolja.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n<ul>\n<li><strong>Kombin\u00e1lt androg\u00e9nblok\u00e1d (CAB)<\/strong> a fejlett vagy metastatikus prosztatar\u00e1kban (LHRH-agonist\u00e1val kombin\u00e1lva)<\/li>\n<li><strong>Tumor fell\u00e1ngol\u00e1s megel\u0151z\u00e9se<\/strong> LHRH-agonistakezel\u00e9s megkezd\u00e9sekor (2\u20134 h\u00e9ttel a kezel\u00e9s el\u0151tt)<\/li>\n<li><strong>Monotherapy 150 mg\/day<\/strong> in locally advanced non-metastatic prostate cancer (alternative to LHRH agonist for patients prioritising sexual function preservation)<\/li>\n<li><strong>Biok\u00e9miai recid\u00edva ut\u00e1n<\/strong> szakaszos vagy folyamatos androg\u00e9ndepriv\u00e1ci\u00f3s kezel\u00e9sek r\u00e9szek\u00e9nt<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Bicalumutide Dosage and How to Take<\/h2>\n<p>Standard adag: <strong>50 mg once daily (with LHRH agonist) or 150 mg once daily (monotherapy)<\/strong>.<\/p>\n<ol>\n<li><strong>Naponta egyszer, mindig ugyanabban az id\u0151pontban.<\/strong> With or without food.<\/li>\n<li><strong>V\u00edzben t\u00f6rt\u00e9n\u0151 lenyel\u00e9sre.<\/strong><\/li>\n<li><strong>K\u00f6telez\u0151 monitoroz\u00e1s:<\/strong> alapvizsg\u00e1latk\u00e9nt m\u00e1jfunkci\u00f3s tesztek (AST, ALT) \u00e9s PSA. A m\u00e1jfunkci\u00f3s tesztek ism\u00e9tl\u00e9se <strong>havonta az els\u0151 4 h\u00f3napban<\/strong>, majd 3\u20136 havonta. PSA 3 havonta. Megszak\u00edt\u00e1s \u00e9s vizsg\u00e1lat, ha az AST\/ALT &gt; 3\u00d7 a norm\u00e1l fels\u0151 hat\u00e1r\u00e9rt\u00e9k.<\/li>\n<li><strong>LHRH-agonistakezel\u00e9s el\u0151tti tumorflair megel\u0151z\u00e9se:<\/strong> start Bicalumutide 2&ndash;4 weeks before LHRH agonist initiation, continue for at least 1 month after.<\/li>\n<li><strong>Ne szak\u00edtsa meg onkol\u00f3gus utas\u00edt\u00e1sa n\u00e9lk\u00fcl.<\/strong><\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Bicalumutide<\/h2>\n<p><strong>Gyakori:<\/strong><\/p>\n<ul>\n<li>Ginekomastia \u00e9s mellf\u00e1jdalom (40\u201370% monoter\u00e1pi\u00e1n\u00e1l; kevesebb CAB mellett)<\/li>\n<li>H\u0151hull\u00e1mok<\/li>\n<li>Cs\u00f6kkent libid\u00f3 \u00e9s mereved\u00e9si zavarok<\/li>\n<li>F\u00e1radts\u00e1g, gyenges\u00e9g<\/li>\n<li>Hasmen\u00e9s (k\u00fcl\u00f6n\u00f6sen flutamid eset\u00e9n)<\/li>\n<li>Enyhe em\u00e9szt\u0151rendszeri panasz<\/li>\n<\/ul>\n<p><strong>Fontos \u2013 k\u00f6telez\u0151 monitoroz\u00e1s:<\/strong><\/p>\n<ul>\n<li><strong>Hepatotoxicit\u00e1s<\/strong> \u2013 s\u00falyos \u00e9s kisz\u00e1m\u00edthatatlan lehet. Azonnal sz\u00fcneteltetni kell s\u00e1rgas\u00e1g, s\u00f6t\u00e9t vizelet, s\u00falyos f\u00e1radts\u00e1g vagy AST\/ALT &gt; 3\u00d7 ULN eset\u00e9n. A legt\u00f6bb eset az els\u0151 4 h\u00f3napban fordul el\u0151.<\/li>\n<li>Rare interstitial pneumonitis &mdash; new-onset cough, dyspnoea<\/li>\n<\/ul>\n<p><strong>Ritka:<\/strong> haemolyticus anaemia, f\u00e9ny\u00e9rz\u00e9kenys\u00e9g, s\u00falyos b\u0151rreakci\u00f3k.<\/p>\n<h2 class=\"wp-block-heading\">Figyelmeztet\u00e9sek \u00e9s el\u0151vigy\u00e1zatoss\u00e1g<\/h2>\n<ul>\n<li><strong>Terhess\u00e9g \u00e9s szoptat\u00e1s:<\/strong> nem alkalmazhat\u00f3 (csak f\u00e9rfiakra vonatkoz\u00f3 indik\u00e1ci\u00f3), de az antiandrog\u00e9nek magzati m\u00e9rgez\u0151 hat\u00e1s\u00faak, ha terhess\u00e9g alatt v\u00e9letlen\u00fcl szedik.<\/li>\n<li><strong>M\u00e1jfunkci\u00f3:<\/strong> K\u00f6telez\u0151 havi m\u00e1jfunkci\u00f3s tesztek az els\u0151 4 h\u00f3napban. Sz\u00fcneteltetni, ha az AST\/ALT &gt; 3\u00d7 ULN.<\/li>\n<li><strong>Diabetes:<\/strong> rombolhatja a glik\u00e9mi\u00e1s kontrollt.<\/li>\n<li><strong>Sz\u00edv- \u00e9s \u00e9rrendszeri:<\/strong> Az ADT \u00e1ltal\u00e1ban n\u00f6veli a sz\u00edv- \u00e9s \u00e9rrendszeri esem\u00e9nyek kock\u00e1zat\u00e1t. Optimaliz\u00e1lja a m\u00f3dos\u00edthat\u00f3 kock\u00e1zati t\u00e9nyez\u0151ket.<\/li>\n<li><strong>Ginekomastia megel\u0151z\u00e9s:<\/strong> alacsony d\u00f3zis\u00fa tamoxifen 10\u201320 mg\/nap vagy megel\u0151z\u0151 mellkasi sug\u00e1rkezel\u00e9s cs\u00f6kkenti az el\u0151fordul\u00e1st (szakorvos).<\/li>\n<li><strong>Vezet\u00e9s:<\/strong> \u00f3vatosan \u2013 a f\u00e1radts\u00e1g \u00e9s sz\u00e9d\u00fcl\u00e9s ronthatja a vezet\u00e9si k\u00e9pess\u00e9get.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Kombin\u00e1lhat\u00f3<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Hat\u00e1s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Teend\u0151k<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Varfarin \u00e9s egy\u00e9b kumarin sz\u00e1rmaz\u00e9k\u00fa antikoagul\u00e1nsok<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Jelent\u0151s INR-emelked\u00e9s \u2013 v\u00e9rz\u00e9si kock\u00e1zat<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ellen\u0151rizze az INR-t hetente kezdetben. Cs\u00f6kkentse a varfarin d\u00f3zist 30\u201350%-kal.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">CYP3A4 inhibitors (minor effect)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raise bicalutamide levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitorozza a m\u00e1jm\u00e9rgez\u00e9s jeleit.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">LHRH agonist\u00e1k (goszerelin, leuprorelin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard kombin\u00e1ci\u00f3 \u2013 kombin\u00e1lt androg\u00e9n blok\u00e1d<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard CAB kezel\u00e9si s\u00e9ma.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alkohol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Addit\u00edv m\u00e1jm\u00e9rgez\u00e9s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Korl\u00e1tozza az alkoholfogyaszt\u00e1st a kezel\u00e9s alatt.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<ul>\n<li>Szobah\u0151m\u00e9rs\u00e9kleten, 15\u201325\u00b0C k\u00f6z\u00f6tt t\u00e1rolja, eredeti blistercsomagol\u00e1sban.<\/li>\n<li>T\u00e1vol tartand\u00f3 gyermekekt\u0151l, n\u0151kt\u0151l \u00e9s h\u00e1zi\u00e1llatokt\u00f3l \u2013 az antiandrog\u00e9nek magzati m\u00e9reghat\u00e1ssal b\u00edrnak.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k a MedsBase-en<\/h2>\n<p>Tov\u00e1bbi onkol\u00f3giai gy\u00f3gyszerek, amelyek e term\u00e9k mellett el\u00e9rhet\u0151k:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/bdenza\/\"><strong>Bdenza (enzalutamide 40 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/cytomid\/\"><strong>Cytomid (flutamid 250 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/hu\/anti-cancer-medication\/\">\u00d6sszes r\u00e1kkel szembeni gy\u00f3gyszer b\u00f6ng\u00e9sz\u00e9se \u2192<\/a><\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Why is Bicalumutide usually combined with an LHRH agonist?<\/h3>\n<p>LHRH agonists (goserelin, leuprorelin) suppress testicular androgen production, but the adrenal glands continue producing ~10% of body androgens that can drive prostate cancer growth. Bicalumutide blocks the androgen receptor itself, so adrenal androgens cannot signal. The combination is called <strong>kombin\u00e1lt androg\u00e9nblok\u00e1d (CAB) c\u00e9lj\u00e1b\u00f3l<\/strong> nek nevezik, \u00e9s m\u00e9lyebb androg\u00e9nszuppresszi\u00f3t eredm\u00e9nyez, mint az LHRH-agonist\u00e1k \u00f6nmagukban a fejlett betegs\u00e9gben.<\/p>\n<h3 class=\"wp-block-heading\">What is &ldquo;tumour flare&rdquo; and why does Bicalumutide prevent it?<\/h3>\n<p>When LHRH agonist therapy starts, the pituitary is initially stimulated and testosterone surges for 1&ndash;2 weeks before downregulation kicks in. In patients with significant disease burden (bone metastases, urinary obstruction, spinal cord compression risk), this transient testosterone surge can worsen symptoms acutely. Starting Bicalumutide 2&ndash;4 weeks before the LHRH agonist blocks the receptor and prevents the flare.<\/p>\n<h3 class=\"wp-block-heading\">Hogyan kezelik a gynecomasti\u00e1t?<\/h3>\n<p>A mellf\u00e1jdalom \u00e9s gynecomastia a bicalutamid monoter\u00e1pi\u00e1n r\u00e9szes\u00fcl\u0151 betegek 40\u201370%-\u00e1t \u00e9rinti magasabb d\u00f3zisokn\u00e1l. Megel\u0151z\u00e9si lehet\u0151s\u00e9gek: <strong>alacsony d\u00f3zis\u00fa tamoxifen 10\u201320 mg\/nap<\/strong> (a legt\u00f6bb bizony\u00edt\u00e9k) vagy <strong>profilaktikus eml\u0151besug\u00e1rz\u00e1s<\/strong> egyetlen 8\u201312 Gy frakci\u00f3k\u00e9nt az antiandrog\u00e9n kezel\u00e9s megkezd\u00e9se el\u0151tt. Besz\u00e9lje meg az onkol\u00f3gussal a kezel\u00e9s megkezd\u00e9se el\u0151tt, ha a kozmetikai agg\u00e1lyok jelent\u0151sek.<\/p>\n<h3 class=\"wp-block-heading\">Milyen v\u00e9rvizsg\u00e1latokra van sz\u00fcks\u00e9gem?<\/h3>\n<p><strong>K\u00f6telez\u0151:<\/strong> alapvizsg\u00e1lat: m\u00e1jfunkci\u00f3s tesztek (AST, ALT) \u00e9s PSA. Ezut\u00e1n m\u00e1jfunkci\u00f3s tesztek <strong>havonta az els\u0151 4 h\u00f3napban<\/strong>, then every 3&ndash;6 months. PSA every 3 months. Stop Bicalumutide immediately and contact your oncologist if AST\/ALT &gt; 3&times; ULN, or for any jaundice, dark urine or severe fatigue.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol on Bicalumutide?<\/h3>\n<p>Limit alcohol &mdash; both alcohol and bicalutamide are hepatotoxic and the combination amplifies the risk of severe drug-induced liver injury. Occasional small amounts are usually tolerable; heavy or daily drinking should be avoided throughout treatment.<\/p>\n<h3 class=\"wp-block-heading\">Bicalumutide vs flutamide vs enzalutamide &mdash; what is the difference?<\/h3>\n<p>All three are oral anti-androgens for prostate cancer. <strong>Bicalutamide:<\/strong> once-daily, well-tolerated, standard first-generation choice. <strong>Flutamide:<\/strong> three-times-daily, more diarrhoea and hepatotoxicity risk &mdash; largely replaced by bicalutamide. <strong>Bdenza vezethet\u0151-e?<\/strong> second-generation, more potent, used for castration-resistant disease (after CAB has failed) &mdash; see <a href=\"https:\/\/medsbase.com\/hu\/bdenza\/\">Bdenza<\/a>.<\/p>\n<h3 class=\"wp-block-heading\">Will Bicalumutide affect my heart?<\/h3>\n<p>Az antiandrog\u00e9n monoter\u00e1pi\u00e1nak minim\u00e1lis k\u00f6zvetlen kardiovaszkul\u00e1ris hat\u00e1sa van, de a sz\u00e9lesebb k\u00f6r\u0171 androgen-depriv\u00e1ci\u00f3s ter\u00e1pia (LHRH agonista + antiandrog\u00e9n) fokozott kardiovaszkul\u00e1ris esem\u00e9nyekkel, p\u00e9ld\u00e1ul sz\u00edvinfarktussal \u00e9s agyv\u00e9rz\u00e9ssel j\u00e1rhat. Optimaliz\u00e1lja a kardiovaszkul\u00e1ris kock\u00e1zati t\u00e9nyez\u0151ket: v\u00e9rnyom\u00e1s-szab\u00e1lyoz\u00e1s, sztatin hiperlipid\u00e9mia eset\u00e9n, doh\u00e1nyz\u00e1s abbahagy\u00e1sa, testmozg\u00e1s, tests\u00falykezel\u00e9s.<\/p>\n<h3 class=\"wp-block-heading\">Can I stop Bicalumutide if PSA stays low?<\/h3>\n<p>Besz\u00e9lje meg onkol\u00f3gus\u00e1val. Egyes szakaszos CAB protokollokban a CAB-t felf\u00fcggesztik, ha a PSA egy k\u00fcsz\u00f6b\u00e9rt\u00e9k al\u00e1 cs\u00f6kken, \u00e9s folytatj\u00e1k, ha a PSA emelkedik \u2013 ez cs\u00f6kkentheti a mell\u00e9khat\u00e1sokat an\u00e9lk\u00fcl, hogy vesz\u00e9lyeztetn\u00e9 a t\u00fal\u00e9l\u00e9st. Soha ne hagyd abba egyoldal\u00faan \u2013 a PSA monitoroz\u00e1sa \u00e9s az \u00fajraind\u00edt\u00e1s id\u0151z\u00edt\u00e9se kritikus fontoss\u00e1g\u00fa.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Titkos\u00edtott fizet\u00e9s<\/strong> \u00b7 <strong>\ud83d\udcb3 Hiteles\u00edtett feldolgoz\u00f3<\/strong> \u00b7 <strong>\ud83d\ude9a Vil\u00e1gszerte sz\u00e1ll\u00edtunk<\/strong> \u00b7 <strong>\u2b50 4,9\/5 1400+ \u00fcgyf\u00e9lt\u0151l<\/strong>\n<\/div>\n<p><!-- medsbase-why-order --><\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Minden t\u00e9tel egy <strong>WHO-GMP tan\u00fas\u00edtott gy\u00e1rt\u00f3<\/strong>. WHO-GMP <a href=\"\/hu\/medsbase-re-shipment-assurance-policy\/\">\u00dajrak\u00fcld\u00e9si Garancia<\/a>: ha egy csomag nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, ingyenes ut\u00e1nk\u00fcld\u00e9st biztos\u00edtunk, k\u00e9rd\u00e9sek n\u00e9lk\u00fcl.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/riborea\/\">Riborea<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/bacloheal\/\">Bacloheal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/amlode\/\">Amlode<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/nicerbium\/\">Nicerbium<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/lipril-h\/\">Lipril-H<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Kezeli a prosztatar\u00e1kot<br \/>\n\u2705 Blocks male hormones<br \/>\n\u2705 Lass\u00edtja a daganat n\u00f6veked\u00e9s\u00e9t<br \/>\n\u2705 T\u00fal\u00e9l\u00e9si ar\u00e1nyok jav\u00edt\u00e1s\u00e1ra<br \/>\n\u2705 Reduces cancer symptoms<\/p>\n<p>Bicalumutide contains Bicalutamide.<\/p>","protected":false},"featured_media":61597,"comment_status":"closed","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3614,3141,3223,3342],"product_tag":[5066,5067],"class_list":{"0":"post-61596","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-bladder-prostate","8":"product_cat-category-overview","9":"product_cat-chronic-conditions","10":"product_cat-general-health","11":"product_tag-bicalumutide","12":"product_tag-bicalutamide","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/61596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=61596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/61597"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=61596"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=61596"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=61596"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=61596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}